1.Management of prevention and treatment of chronic diseases after kidney transplantation
Organ Transplantation 2026;17(2):192-197
Kidney transplantation is the most ideal treatment method for end-stage renal disease, significantly improving the survival rate and quality of life of patients. However, as the postoperative survival period gradually lengthens, chronic diseases have become the main obstacle affecting the long-term outcome of kidney transplantation. These chronic diseases have a high incidence, involve multiple organs and significantly impact prognosis. The core driving factors are mainly related to long-term immunosuppressive therapy. This article systematically discusses the occurrence mechanisms, prevention and treatment strategies, and classification management of common chronic diseases after kidney transplantation (mainly including chronic graft dysfunction, cardiovascular diseases, infections, malignant tumors, bone metabolism disorders, etc.). At the same time, it explores future development directions such as precision medicine, new immune modulators and remote management, emphasizing a comprehensive management model centered on "multidisciplinary collaboration + individualized treatment + continuous monitoring" to achieve long-term, systematic, and dynamic prevention and treatment of chronic diseases for kidney transplant recipients.
2.Chinese Medicine in Treatment of Ulcerative Colitis by Regulating JAK2/STAT3 Signaling Pathway: A Review
Renxun ZHANG ; Jinwen LI ; Wang DING ; Yuanqing JI ; Jing CHEN ; Zhixia HU ; Xiaopeng DONG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):273-283
Ulcerative colitis (UC) is a chronic nonspecific inflammatory intestinal disease with a complex pathogenesis. Its recurrent attacks easily lead to persistent intestinal mucosal damage, resulting in a year-by-year increase in incidence and imposing a heavy burden on patients. Currently, the treatment of UC mainly relies on corticosteroids, immunosuppressants, and aminosalicylate preparations. However, these therapies are limited by significant side effects, strong drug resistance, and poor long-term prognosis. As one of the important inflammatory pathways, the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway can regulate the occurrence and development of UC through multiple pathways by modulating multiple downstream targets. Therefore, the JAK2/STAT3 signaling pathway offers a new research direction for the treatment of UC. Numerous studies have shown that the JAK2/STAT3 signaling pathway plays an important role in intestinal inflammatory responses, intestinal mucosal barrier damage, T helper cell 17 (Th17)/regulatory T cell (Treg) immune imbalance, intestinal epithelial cell apoptosis, and oxidative stress. Chinese medicine has attracted increasing attention because of its unique advantages, including fewer side effects, individualized diagnosis and treatment, and enhancement of efficacy with reduction of toxicity. In addition to traditional Chinese herbal formulas, more Chinese medicine monomers and extracts have played key roles because of their more precise therapeutic targets. In recent years, many studies have confirmed that Chinese medicine can exert therapeutic effects on UC by interfering with the JAK2/STAT3 signaling pathway, thereby alleviating intestinal inflammatory responses, repairing the intestinal mucosal barrier, regulating the balance of Th17/Treg immune cells, inhibiting intestinal epithelial cell apoptosis, and suppressing oxidative stress. This article summarizes and reviews recent research progress in this field from three aspects, including an overview of the JAK2/STAT3 signaling pathway, the relationship between the JAK2/STAT3 signaling pathway and UC, and the regulatory mechanisms of traditional Chinese medicine, with the aim of providing a theoretical basis for the future clinical treatment of UC and drug development.
3.Chinese Medicine in Treatment of Ulcerative Colitis by Regulating JAK2/STAT3 Signaling Pathway: A Review
Renxun ZHANG ; Jinwen LI ; Wang DING ; Yuanqing JI ; Jing CHEN ; Zhixia HU ; Xiaopeng DONG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):273-283
Ulcerative colitis (UC) is a chronic nonspecific inflammatory intestinal disease with a complex pathogenesis. Its recurrent attacks easily lead to persistent intestinal mucosal damage, resulting in a year-by-year increase in incidence and imposing a heavy burden on patients. Currently, the treatment of UC mainly relies on corticosteroids, immunosuppressants, and aminosalicylate preparations. However, these therapies are limited by significant side effects, strong drug resistance, and poor long-term prognosis. As one of the important inflammatory pathways, the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway can regulate the occurrence and development of UC through multiple pathways by modulating multiple downstream targets. Therefore, the JAK2/STAT3 signaling pathway offers a new research direction for the treatment of UC. Numerous studies have shown that the JAK2/STAT3 signaling pathway plays an important role in intestinal inflammatory responses, intestinal mucosal barrier damage, T helper cell 17 (Th17)/regulatory T cell (Treg) immune imbalance, intestinal epithelial cell apoptosis, and oxidative stress. Chinese medicine has attracted increasing attention because of its unique advantages, including fewer side effects, individualized diagnosis and treatment, and enhancement of efficacy with reduction of toxicity. In addition to traditional Chinese herbal formulas, more Chinese medicine monomers and extracts have played key roles because of their more precise therapeutic targets. In recent years, many studies have confirmed that Chinese medicine can exert therapeutic effects on UC by interfering with the JAK2/STAT3 signaling pathway, thereby alleviating intestinal inflammatory responses, repairing the intestinal mucosal barrier, regulating the balance of Th17/Treg immune cells, inhibiting intestinal epithelial cell apoptosis, and suppressing oxidative stress. This article summarizes and reviews recent research progress in this field from three aspects, including an overview of the JAK2/STAT3 signaling pathway, the relationship between the JAK2/STAT3 signaling pathway and UC, and the regulatory mechanisms of traditional Chinese medicine, with the aim of providing a theoretical basis for the future clinical treatment of UC and drug development.
4.Chemical synthesis of trisaccharide intermediates related to Streptococcus pneumoniae serotype 9N capsular polysaccharide
Ziyue CHEN ; Chunjun QIN ; Junjie FU ; Guangzong TIAN ; Xiaopeng ZOU ; Jing HU ; Jian YIN
Journal of China Pharmaceutical University 2026;57(5):607-614
Streptococcus pneumoniae (SP) is a key pathogen that induces various infectious diseases such as pneumonia, otitis media, and meningitis. As a core immunogen, its capsular polysaccharide serves as the key target for the research and development of pneumococcal vaccines. The chemical synthesis of structurally well-defined and homogeneous oligosaccharides plays a pivotal role in elucidating the structure-activity relationship underlying the immunological activity of polysaccharides and in the development of novel glycoconjugate vaccines. This study achieved the efficient chemical synthesis of two trisaccharide intermediates of the capsular polysaccharide from Streptococcus pneumoniae serotype 9N. Starting from readily available D-mannose and D-glucose, a reducing-end to non-reducing-end synthetic strategy was adopted. By optimizing key reaction parameters including protecting group screening and solvent effect regulation, two types of 1,2-cis glycosidic linkages were efficiently constructed. Specifically, the yield of the 1,2-cis-α-glycosidic bond reached 90%, whereas that of the 1,2-cis-β-glycosidic bond was tripled, with its stereoselectivity significantly improved. Furthermore, the issue of low nucleophilicity at the C4 position of amino sugars was resolved by the introduction of electron-donating protecting groups at the hydroxy groups adjacent to the receptor glycosylation sites. Eventually, two target trisaccharide intermediates were efficiently synthesized in 11 and 10 total steps, respectively, laying a solid foundation for the preparation of the pentasaccharide repeating unit and longer-chain oligosaccharides of the Streptococcus pneumoniae serotype 9N capsular polysaccharide.
5.Efficacy of laparoscopic radical cystectomy with indocyanine green fluorescence imaging versus standard lymph node dissection: a randomized comparative study
Lifeng LIU ; Na CAO ; Yansong GUO ; Hao WANG ; Xiaopeng WANG ; Fengshuo YANG ; Yuepeng HU ; Longjiang TIAN ; Dawei TIAN
Journal of Modern Urology 2025;30(3):212-214
Objective: To investigate the efficacy,safety and feasibility of regional lymph node dissection in laparoscopic radical surgery for bladder cancer under the guidance of indocyanine green fluorescence imaging. Methods: A total of 30 patients with muscle invasive bladder cancer (T2/T3NxM0) who volunteered to enter the clinical trial were randomly divided into the indocyanine green imaging guided laparoscopic regional lymph node dissection group (n=15) and the standard pelvic lymph node dissection group (n=15).The number of positive lymph nodes,operation time,intraoperative bleeding volume,incidence of lymph leakage,and tumor recurrence and metastasis rate 2-year after surgery were collected. Results: The number of positive lymph nodes was (4.20±1.66) and (4.60±1.72) respectively in the indocyanine green and standard groups,with no statistically significant difference (P>0.05).There were no statistically significant difference in the tumor recurrence and metastasis rates 2-year after surgery between the two groups (P>0.05).However,the indocyanine green group had shorter operation time,less intraoperative bleeding volume,and lower incidence of lymphatic leakage than the standard group (P<0.05). Conclusion: Indocyanine green fluorescence imaging guided laparoscopic lymph node dissection has comparable clinical efficacy to standard lymph node dissection,but with fewer complications.
6.Analysis of risk factor for complications following lateral lumbar interbody fusion surgery
Xiaopeng LI ; Haochen HU ; Penghe LI ; Wentao WAN ; Bing CHEN ; Feng LI ; Haiyun YANG ; Gang LIU ; Chao CHEN ; Xinlong MA ; Qiang YANG
Chinese Journal of Orthopaedics 2025;45(18):1177-1183
Objective:To investigate the risk factors for complications following lateral lumbar interbody fusion (LLIF) surgery.Methods:A retrospective analysis was conducted on 196 patients who underwent LLIF surgery via the psoas major muscle approach in the Department of Spinal Surgery, Tianjin Hospital, Tianjin University, from October 2018 to July 2024. The age, gender, body mass index (BMI), presence of hypertension, type 2 diabetes, heart disease, osteoporosis, history of lumbar surgery, history of abdominal surgery, history of abdominal inflammation, smoking status, operative time, surgical segments (whether the surgery was single-segment or multi-segments), and use of internal fixation or not were compared between patients with and without postoperative complications, the indicators with P<0.10 were included in the binary variable logistic regression analysis, and determine the independent risk factors for complications after LLIF surgery. Complications included anterior thigh symptoms (pain, numbness, weakness), cage subsidence, surgery-related complications (nerve injury, surgical site infection, postoperative buttock pain, urinary and fecal incontinence, etc.), and medical complications (cerebrovascular accident, deep vein thrombosis, urinary tract infection, etc.). Results:All 196 patients were followed up for 27.02 (12.6, 40.69) months. Postoperative complications occurred in 71 cases (96 times), and no complications occurred in 125 cases. In the complication group, there were 15 males and 56 females with a mean age of 61.82±7.57 years; in the non-complication group, there were 43 males and 82 females with a mean age of 62.00± 8.39 years. In the complication group, there were 43 cases of anterior thigh symptoms, 38 cases of cage subsidence, 11 cases of surgical operation-related complications, and 4 cases of medical complications. There were statistically significant differences in gender (χ 2=3.829, P=0.051), operation time ( t=2.391, P=0.018), and surgical segment (χ 2=4.245, P=0.039) between the complication group and the non-complication group. No statistically significant differences were found in age, gender, BMI, presence of hypertension, type 2 diabetes, heart disease, osteoporosis, history of lumbar surgery, history of abdominal surgery, history of abdominal inflammation, smoking status, or use of internal fixation ( P>0.10). Binary variable logistic regression analysis indicated that prolonged operative time [ OR=1.007, 95% CI(1.001, 1.013), P=0.019] and multilevel surgery [ OR=2.099, 95% CI(1.095, 4.025), P=0.026] were independent risk factors for complications following LLIF. Conclusion:Prolonged operative time and multi-segments surgery are independent risk factors for complications following LLIF.
7.Construction of a Nomogram risk prediction model for deep vein thrombosis in patients with knee osteoarthritis after artificial total knee arthroplasty
Peng LIU ; Xiaopeng WANG ; Linfeng HU
Journal of Shenyang Medical College 2025;27(1):55-60
Objective:To investigate the factors influencing the occurrence of deep vein thrombosis(DVT)in patients with knee osteoarthritis after artificial total knee arthroplasty(TKA)and to construct a nomogram prediction model.Methods:A total of 120 patients with knee osteoarthritis underwent TKA from Dec 2020 to Dec 2022 were selected.The patients were divided into DVT group(n=20)and non-DVT group(n=100)according to whether DVT occurred after surgery.Receiver operating characteristic(ROC)curve was used to analyze the predictive value of each influencing factor to the occurrence of DVT.Multivariable logistic regression was used to analyze the factors affecting the occurrence of DVT.The nomogram prediction model of DVT was constructed by the R software 4.0"rms"package.The calibration and decision curves were used to internally validate and clinically assess the predictive efficacy of the nomogram prediction model.Results:There were significant differences between DVT group and non-DVT group in age,body mass index(BMI),diabetes mellitus,hyperlipidaemia,plasma D-dimer level,operative time,intraoperative haemorrhage,post-operative bedrest,and anaesthesia modality(P<0.05).ROC curve showed that the AUC for age,BMI,plasma D-dimer,operative time,intraoperative haemorrhage,and postoperative bedrest were 0.663,0.678,0.985,0.856,0.925 and 0.925,respectively.Multivariable logistic regression analysis showed that age≥71 years old,BMI≥25.47 kg/m2,diabetes mellitus,hyperlipidaemia,plasma D-dimer level≥0.69 mg/L,and general anaesthesia were independent risk factors for postoperative DVT(P<0.05).The calibration curve of the nomogram prediction model was close to the original and ideal curves,with a C-index of 0.813(0.721-0.905),indicating a high degree of fit.The threshold value of the nomogram prediction model was>0.17,which could provide a net clinical benefit.And its net clinical benefit was higher than age,BMI,diabetes mellitus,hyperlipidemia,plasma D-dimer,and anaesthesia mode.Conclusions:The factors affecting the occurrence of DVT in patients with knee osteoarthritis after TKA are age,BMI,diabetes mellitus,hyperlipidaemia,plasma D-dimer level,operative time,intraoperative haemorrhage,postoperative bedtrest,and anaesthesia mode.The personalized neomorph prediction model constructed by these predictive factors can help to predict and evaluate whether DVT will be occurred in patients with knee osteoarthritis after TKA,so as to intervene early,reduce the incidence and improve the prognosis.
8.Digital three-dimensional assisted unilateral biportal endoscopy in treatment of highly isolated lumbar disc herniation with translaminar approach.
Weiliang SU ; Suni LU ; Dong LIU ; Jianqiang XING ; Peng HU ; Yongfeng DOU ; Xiaopeng GENG ; Dawei WANG
Chinese Journal of Reparative and Reconstructive Surgery 2025;39(3):346-353
OBJECTIVE:
To investigate the effectiveness of digital three-dimensional (3D) assisted unilateral biportal endoscopy (UBE) in the treatment of highly isolated lumbar disc herniation (LDH) with translaminar approach.
METHODS:
The clinical data of 59 patients who met the selection criteria and underwent UBE treatment due to highly isolated LDH between January 2022 and December 2023 were retrospectively analyzed. Among them, 25 cases were treated with digital 3D assisted translaminar approach (observation group) and 34 cases were treated with interlaminar approach (control group). There was no significant difference in gender, age, disease duration, surgical segment, and preoperative visual analogue scale (VAS) score and Oswestry disability index (ODI) between the two groups ( P>0.05). The operation time, intraoperative blood loss, and lateral articular surface preservation rate were recorded and compared between the two groups. VAS score and ODI were used to evaluate the improvements of pain and function before operation and at 3 and 6 months after operation. The modified MacNab criteria was used to evaluate the effectiveness at last follow-up.
RESULTS:
One patient in the control group had dural tear, and the other patients had no nerve injury, infection, dural tear, or other related complications. There was no significant difference in operation time and intraoperative blood loss between the two groups ( P>0.05). Patients in both groups were followed up 6-13 months, with an average of 8.3 months. The lateral articular surface preservation rate in the observation group was significantly higher than that in the control group ( P<0.05). Three patients in the observation group and 2 patients in the control group had calf muscle venous thrombosis, which was cured after anticoagulant treatment with rivaroxaban and delayed exercise time. There was no recurrence or second operation during the follow-up period. The VAS score and ODI of the two groups at 3 and 6 months after operation significantly improved when compared with those before operation ( P<0.05). There was no significant difference between the two groups at each time point after operation ( P>0.05). At last follow-up, the effectiveness was evaluated according to the modified MacNab criteria, and there was no significant difference in the evaluation grade and excellent and good rate between the two groups ( P>0.05).
CONCLUTION
UBE via translaminar approach is safe and effective for the treatment of highly isolated LDH, which is beneficial to protect the facet joint, maintain spinal stability, and reduce soft tissue injury. With the assistance of digital 3D technique, preoperative planning can be performed accurately.
Humans
;
Intervertebral Disc Displacement/diagnostic imaging*
;
Lumbar Vertebrae/diagnostic imaging*
;
Male
;
Retrospective Studies
;
Female
;
Endoscopy/methods*
;
Treatment Outcome
;
Middle Aged
;
Adult
;
Imaging, Three-Dimensional
;
Operative Time
;
Pain Measurement
9.Guidelines for vaccination of kidney transplant candidates and recipients in China
Jian Zhang ; Jun Lin ; Weijie Zhang ; Xiaoming Ding ; Xiaopeng Hu ; Wujun Xue
Organ Transplantation 2025;16(2):177-190
In order to further standardize the vaccination of kidney transplant candidates and recipients in China, the Branch of Organ Transplantation of Chinese Medical Association has organized experts in kidney transplantation and infectious diseases. Based on the "Vaccination of Solid Organ Transplant Candidates and Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice", and in combination with the clinical reality of infectious diseases and vaccination after organ transplantation in China, as well as referring to relevant recommendations from home and abroad in recent years, these guidelines are formulated from aspects such as epidemiology, types of vaccines, vaccination principles, target population, and specific vaccine administration. The "Guidelines for Vaccination of Kidney Transplant Candidates and Recipients in China" aims to provide theoretical reference for medical workers in the field of kidney transplantation in China, regarding the vaccination of kidney transplant candidates and recipients. It is expected to better guide the vaccination of kidney transplant candidates and recipients, reduce the risk of postoperative infection, and improve survival outcomes.
10.Engineered Escherichia coli Nissle 1917 targeted delivery of extracellular PD-L1-mFc fragment for treating inflammatory bowel disease.
Yuhong WANG ; Lin HU ; Lei WANG ; Chonghai ZHANG ; Wenhao SHEN ; Hongli YANG ; Min LI ; Xin ZHANG ; Mengmeng XU ; Muxing ZHANG ; Kai YANG ; Xiaopeng TIAN
Acta Pharmaceutica Sinica B 2025;15(11):6019-6033
Inflammatory bowel disease (IBD) is an autoimmune disorder involving complex immune regulation, where balancing localized and systemic immunosuppression is a key challenge. This study aimed to enhance the therapeutic efficacy by engineering the probiotic Escherichia coli Nissle 1917 (EcN). We removed endogenous plasmids pMUT1 and pMUT2 from wild-type EcN and expressed the mPD-L1 (19‒238 aa)-mFc fusion protein on the bacterial surface using a cytolysin A (ClyA) fragment. This modification stabilized mPD-L1 (19‒238 aa) protein expression and promoted its recruitment to outer membrane vesicles (OMVs). The engineered strain, EcNΔpMUT1/2-ClyA-mPD-L1-mFc (EcN-ePD-L1-mFc), features conditional ePD-L1-mFc expression under the araBAD promoter, enhancing gut-targeted release and reducing systemic side effects. This strain improved treatment targeting and efficiency by enabling direct ePD-L1-mFc interaction with immune cells at inflammation sites. OMVs from this strain induced Treg proliferation, inhibited effector T cell proliferation in vitro, and significantly improved intestinal inflammation and colonic epithelial barrier repair in vivo. Additionally, the bacterium restored intestinal microbiota balance, increasing Lactobacillaceae and reducing Bacteroides. This study highlights the engineered bacterium's potential for targeted intestinal immune modulation and offers a novel local IBD treatment approach with promising clinical prospects.

Result Analysis
Print
Save
E-mail